Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

3 Can't-Miss FDA Actions Coming in December
Motley Fool
Tue, 11/26/13 - 04:42 pm
Tags:
FDA, Gilead Sciences, sofosbuvir, Forxiga, AstraZeneca, Bristol-Myers Squibb, GSK, Anoro Ellipta, Theravance
New Hepatitis C Drug Success Should Drive Gilead Sciences In 2014
Seeking Alpha
Tue, 11/26/13 - 04:37 pm
Tags:
hepatitis C, Gilead Sciences, sofosbuvir
Gilead And AbbVie Battle For Top Spot In $20 Billion Hepatitis Drug Market
Seeking Alpha
Sun, 11/24/13 - 12:24 pm
Tags:
Gilead Sciences, AbbVie, hepatitis, hepatitis C, sofosbuvir, ABT-450, ABT-333, ABT-267
Gilead's HIV-1 Drug Wins Approval in Europe
Motley Fool
Tue, 11/19/13 - 07:37 am
Tags:
HIV-1, Gilead Sciences, Vitekta, Europe
Don't Crown the Hepatitis C Drug Winner Just Yet
Motley Fool
Tue, 11/19/13 - 07:35 am
Tags:
hepatitis C, Gilead Sciences, ABT-333, Ribavirin, ABT-450, ritonavir, ABT-267, AbbVie
Gilead Five-year Revenue Outlook, Part 1
Seeking Alpha
Tue, 11/12/13 - 01:10 pm
Tags:
Gilead Sciences
How Much? A Battle Over The Cost Of The New Hepatitis C Drugs
Pharmalot
Mon, 11/11/13 - 11:40 am
Tags:
hepatitis C, drug pricing, sofosbuvir, FDA, Gilead Sciences
Gilead Sciences and Johnson & Johnson Push Vertex Out of Hepatitis C Race
Motley Fool
Sun, 11/3/13 - 12:06 pm
Tags:
Gilead Sciences, JNJ, Vertex Pharmaceuticals, hepatitis, hepatitis B
This Week in Biotech: Twitter Edition
Motley Fool
Sat, 11/2/13 - 11:36 am
Tags:
Gilead Sciences, PDL Biopharma, Depomed, Vertex Pharmaceuticals, JNJ, Sarepta Therapeutics
The Surprising Company Taking On America's Most Fatal Disease
Motley Fool
Fri, 11/1/13 - 11:46 am
Tags:
Ranexa, Gilead Sciences, angina, cardiovascular disease
Gilead Sciences' CEO Discusses Q3 2013 Results - Earnings Call Transcript
Yahoo/Seeking Alpha
Wed, 10/30/13 - 09:46 am
Tags:
Gilead Sciences, earnings
This Week in Biotech
Motley Fool
Sun, 10/27/13 - 12:48 pm
Tags:
Immunomedics, Zogenix, Gilead Sciences, Osiris Therapeutics, Repros Therapeutics
Gilead Stops Leukemia Drug Trial Early on Patient Benefit
Bloomberg
Thu, 10/10/13 - 08:13 am
Tags:
Gilead Sciences, Idelalisib, Rituxan, chronic lymphocytic leukemia
Top Biotechs Set to Win in the War on Cancer
Yahoo/Wall St 24-7
Thu, 10/3/13 - 11:57 am
Tags:
biotech, Biomarin, Immunogen, Ariad Pharmaceuticals, Amgen, Celgene, Gilead Sciences
Insiders Are Selling Gilead Sciences
Seeking Alpha
Sun, 09/29/13 - 01:29 pm
Tags:
Gilead Sciences
3 Companies That Could Make You a Successful Clinical-Stage Biotech Investor
Motley Fool
Sun, 09/29/13 - 01:23 pm
Tags:
Gilead Sciences, Isis Pharmaceuticals, Nektar
Gilead Investors' Nightmare Scenario
Motley Fool
Sat, 09/14/13 - 10:45 am
Tags:
Gilead Sciences
Gilead Is A Gem Of A Biotech Stock Comment Now Follow Comments
Forbes
Sat, 09/7/13 - 11:39 am
Tags:
Gilead Sciences
Gilead Sues Merck Saying New Drug Won’t Infringe Patents
Seeking Alpha
Sat, 08/31/13 - 10:33 am
Tags:
patents, Merck, lawsuits, Gilead Sciences
Crowning the New King of Biotech
Motley Fool
Sat, 08/31/13 - 10:32 am
Tags:
Gilead Sciences

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.